Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-d

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514398, 5483255, C07D23330, C07D23332, C07D23370, A61K 31415

Patent

active

060639342

ABSTRACT:
A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of acyclic derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.

REFERENCES:
patent: 2744852 (1956-05-01), Goodman
patent: 2902356 (1959-09-01), Luckenbaugh et al.
patent: 4280008 (1981-07-01), Schoellkopf et al.
patent: 4304782 (1981-12-01), Dumont et al.
patent: 5213607 (1993-05-01), Guaciaro
Gehlert, et al., "Neuropeptide Y Receptor Antagonsts in Obesity," Expert Opinion on Investigational Drugs, vol. 6, No. 12, Dec. 1977, pp. 1827-1838 .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-d will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-260089

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.